Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)
48.22 x 400 49.30 x 100
Post-market by (Cboe BZX)
48.94 -0.29 (-0.59%) 04/21/25 [NYSE]
48.22 x 400 49.30 x 100
Post-market 49.00 +0.06 (+0.12%) 18:19 ET
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
48.16
Day High
49.67
Open 49.35
Previous Close 49.23 49.23
Volume 10,338,600 10,338,600
Avg Vol 13,797,825 13,797,825
Stochastic %K 4.14% 4.14%
Weighted Alpha +1.33 +1.33
5-Day Change -1.77 (-3.49%) -1.77 (-3.49%)
52-Week Range 39.35 - 63.33 39.35 - 63.33
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 100,171,376
  • Shares Outstanding, K 2,034,763
  • Annual Sales, $ 48,300 M
  • Annual Income, $ -8,948 M
  • EBIT $ 493 M
  • EBITDA $ 10,093 M
  • 60-Month Beta 0.41
  • Price/Sales 2.08
  • Price/Cash Flow 8.38
  • Price/Book 6.11

Options Overview Details

View History
  • Implied Volatility 42.37% ( +3.38%)
  • Historical Volatility 33.69%
  • IV Percentile 97%
  • IV Rank 62.96%
  • IV High 55.70% on 04/10/25
  • IV Low 19.71% on 12/26/24
  • Put/Call Vol Ratio 0.37
  • Today's Volume 25,533
  • Volume Avg (30-Day) 32,496
  • Put/Call OI Ratio 0.87
  • Today's Open Interest 556,662
  • Open Int (30-Day) 573,445

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.54
  • Number of Estimates 10
  • High Estimate 1.71
  • Low Estimate 1.43
  • Prior Year -4.40
  • Growth Rate Est. (year over year) +135.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.16 +1.62%
on 04/21/25
Period Open: 61.07
61.64 -20.60%
on 03/31/25
-12.13 (-19.86%)
since 03/21/25
3-Month
48.16 +1.62%
on 04/21/25
Period Open: 57.04
63.33 -22.72%
on 03/11/25
-8.10 (-14.20%)
since 01/21/25
52-Week
39.35 +24.37%
on 07/05/24
Period Open: 48.93
63.33 -22.72%
on 03/11/25
+0.01 (+0.02%)
since 04/19/24

Most Recent Stories

More News
Stocks Set to Open Sharply Lower After Trump’s Push Against Powell, U.S. Economic Data and Tech Earnings in Focus

June S&P 500 E-Mini futures (ESM25) are down -1.09%, and June Nasdaq 100 E-Mini futures (NQM25) are down -1.23% this morning, pointing to a sharply lower open on Wall Street as U.S. President Donald Trump’s...

GOOGL : 147.67 (-2.31%)
AVGO : 166.21 (-2.80%)
VZ : 42.93 (-2.52%)
MRK : 77.85 (-0.19%)
TXN : 145.61 (-1.91%)
UNH : 425.33 (-6.34%)
ESM25 : 5,234.75 (+0.96%)
TSLA : 227.50 (-5.75%)
T : 26.33 (-3.02%)
IBM : 236.22 (-1.08%)
LLY : 818.02 (-2.61%)
NQM25 : 18,092.25 (+0.95%)
Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

JAZZ : 100.34 (-2.37%)
VTRS : 7.57 (+0.13%)
MRK : 77.85 (-0.19%)
ANIP : 68.00 (-1.75%)
BMY : 48.94 (-0.59%)
Gilead vs Bristol Myers: Which Biotech Bigwig is a Better Bet Now?

Gilead Sciences, Inc. GILD and Bristol Myers Squibb BMY are leading biotechnology companies with broad and diverse portfolios and a global footprint.Gilead Sciences is a pioneer in developing treatments...

MRK : 77.85 (-0.19%)
GILD : 104.33 (-0.20%)
BMY : 48.94 (-0.59%)
Stocks Pressured by Fears of a Tariff-Induced Slowdown

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.17%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.18%. June E-mini...

C : 62.69 (-0.89%)
HBAN : 13.47 (-1.46%)
RKLB : 18.65 (-5.52%)
$IUXX : 17,808.30 (-2.46%)
ALGM : 16.53 (-8.47%)
ZNM25 : 110-215 (-0.13%)
FITB : 33.32 (-2.43%)
ESM25 : 5,234.75 (+0.96%)
WFC : 64.01 (-1.08%)
$DOWI : 38,170.41 (-2.48%)
SPY : 513.88 (-2.38%)
DIA : 381.62 (-2.49%)
Strength in Banks and Lower Bond Yields are Boosting Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.45%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.34%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.60%. June E-mini S&P futures (ESM25...

C : 62.69 (-0.89%)
HBAN : 13.47 (-1.46%)
ADI : 174.99 (-0.73%)
RKLB : 18.65 (-5.52%)
$IUXX : 17,808.30 (-2.46%)
ASML : 624.69 (-2.42%)
ALGM : 16.53 (-8.47%)
ZNM25 : 110-215 (-0.13%)
ESM25 : 5,234.75 (+0.96%)
WFC : 64.01 (-1.08%)
AMD : 85.56 (-2.22%)
LRCX : 62.39 (-2.15%)
Stocks Climb on Hopes of a Softer US Tariff Stance

The S&P 500 Index ($SPX ) (SPY ) today is up +0.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.75%. June E-mini S&P futures (ESM25...

RKLB : 18.65 (-5.52%)
$IUXX : 17,808.30 (-2.46%)
ALGM : 16.53 (-8.47%)
ZNM25 : 110-215 (-0.13%)
ESM25 : 5,234.75 (+0.96%)
GFS : 31.36 (-1.07%)
AMD : 85.56 (-2.22%)
LRCX : 62.39 (-2.15%)
$DOWI : 38,170.41 (-2.48%)
SPY : 513.88 (-2.38%)
DIA : 381.62 (-2.49%)
ON : 34.74 (+0.29%)
3 Value Stocks in the Doghouse

3 Value Stocks in the Doghouse

GIII : 24.60 (+1.57%)
ELAN : 8.48 (+0.47%)
BMY : 48.94 (-0.59%)
Here's What to Expect From Bristol-Myers Squibb's Next Earnings Report

Bristol-Myers Squibb is poised to announce its first-quarter results this month, and analysts predict a triple-digit growth in the company’s bottom-line figure.

XLV : 132.57 (-2.16%)
$SPX : 5,158.20 (-2.36%)
BMY : 48.94 (-0.59%)
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks

Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks

CORT : 62.90 (+1.06%)
SUPN : 30.29 (-1.53%)
LLY : 818.02 (-2.61%)
ZTS : 146.85 (-0.89%)
BMY : 48.94 (-0.59%)
Wall Street's euphoria sends US stocks to historic gains after Trump pauses most of his tariffs

U.S. stocks soared to one of their best days in history on a euphoric Wall Street after President Donald Trump said he would back off on most of his tariffs temporarily

$SPX : 5,158.20 (-2.36%)
JNJ : 156.92 (-0.35%)
BAX : 28.54 (-1.21%)
$DOWI : 38,170.41 (-2.48%)
$IUXX : 17,808.30 (-2.46%)
PFE : 22.04 (-0.45%)
DAL : 39.47 (-3.38%)
BMY : 48.94 (-0.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers...

See More

Key Turning Points

3rd Resistance Point 51.20
2nd Resistance Point 50.43
1st Resistance Point 49.69
Last Price 48.94
1st Support Level 48.18
2nd Support Level 47.41
3rd Support Level 46.67

See More

52-Week High 63.33
Fibonacci 61.8% 54.17
Fibonacci 50% 51.34
Last Price 48.94
Fibonacci 38.2% 48.51
52-Week Low 39.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro